Ftse Mib
34.249,77
0,91%
DAX
18.161,01
1,32%
S&P 500
5.099,96
1,02%
NASDAQ Composite
15.927,90
2,03%
Bitcoin
63.753,82
0,54%

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Assistenza
Home Investire Azioni U.S.A. NASDAQ Ironwood Pharmaceuticals Inc (IRWD) Ironwood Pharmaceuticals Inc (IRWD) Notizie

Ironwood Pharmaceuticals Inc

IRWD
7,85
-0,23 (-2,85%)
27 Apr 2024 - Chiuso
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
25/4/202422:01BWIronwood Pharmaceuticals to Host First Quarter 2024 Investor..
28/3/202412:30BWIronwood Pharmaceuticals Announces Positive Results from its..
08/3/202422:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/3/202422:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/3/202422:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29/2/202412:00BWIronwood Pharmaceuticals Announces Positive Topline Results..
23/2/202413:30BWIronwood Pharmaceuticals to Present Four Abstracts at the..
15/2/202413:04EDGAR2Form 8-K - Current report
15/2/202413:00BWIronwood Pharmaceuticals Reports Fourth Quarter and Full..
15/2/202403:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/2/202402:53EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/2/202402:50EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/2/202402:42EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/2/202402:39EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/2/202402:35EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/2/202422:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/2/202422:13EDGAR2Form 144 - Report of proposed sale of securities
09/2/202422:11EDGAR2Form 144 - Report of proposed sale of securities
09/2/202422:09EDGAR2Form 144 - Report of proposed sale of securities
09/2/202422:05EDGAR2Form 144 - Report of proposed sale of securities
01/2/202422:01BWIronwood Pharmaceuticals to Host Fourth Quarter and Full..
19/1/202422:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
19/1/202422:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
19/1/202422:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
19/1/202422:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/1/202401:00BWIronwood Announces Publication in The Lancet..
08/1/202412:05EDGAR2Form 8-K - Current report
08/1/202412:00BWIronwood Pharmaceuticals Maintains FY 2023 Financial..
03/1/202422:01BWIronwood Pharmaceuticals to Present at the 42nd Annual J.P...
19/12/202322:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
18/12/202322:09EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/12/202322:26EDGAR2Form 144 - Report of proposed sale of securities
12/12/202322:01BWIronwood Announces the Completion of Squeeze-Out Merger With..
21/11/202322:01BWIronwood Pharmaceuticals to Participate in the Piper Sandler..
20/11/202322:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/11/202322:05EDGAR2Form 144 - Report of proposed sale of securities
09/11/202322:08EDGAR2Form S-8 - Securities to be offered to employees in employee..
09/11/202322:07EDGAR2Form S-3ASR - Automatic shelf registration statement of..
09/11/202313:07EDGAR2Form 8-K - Current report
09/11/202313:00BWIronwood Pharmaceuticals Reports Third Quarter 2023 Results
26/10/202322:01BWIronwood Pharmaceuticals to Host Third Quarter 2023 Investor..
23/10/202313:30BWIronwood Releases New IBS-C and CIC Data at the American..
16/10/202312:00BWIronwood Pharmaceuticals Presents Positive Final Data from..
05/10/202313:30BWIronwood to Present New Data at NASPGHAN Annual Meeting..
19/9/202323:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
18/9/202323:07EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/9/202322:30EDGAR2Form 8-K/A - Current report: [Amend]
31/8/202322:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/8/202322:21EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/8/202322:20EDGAR2Form 4 - Statement of changes in beneficial ownership of..
Apertura: 8,09 Min: 7,77 Max: 8,17
Chiusura: 8,08

La tua Cronologia

NASDAQ
IRWD
Ironwood Pharmaceuticals
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' CLICCA QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network